Literature DB >> 11106428

Identification of IkappaBalpha as a substrate of Fas-associated phosphatase-1.

Y Nakai1, S Irie, T A Sato.   

Abstract

Fas (APO-1/CD95), a member of the tumor necrosis factor receptor (TNFR)/nerve growth factor receptor (NGFR) superfamily, is a cell-surface molecule that induces apoptosis upon activation. Fas-associated phosphatase-1 (FAP-1) is a 250-kDa protein tyrosine phosphatase (PTP) that is associated with the negative regulatory domain of Fas (C-terminal 15 amino acids). Human tumor cell lines become resistant to Fas-mediated apoptosis when transfected with FAP-1, indicating that FAP-1 functions as a negative regulator in Fas-mediated death signaling. However, the mechanisms by which FAP-1 inhibits apoptosis are still unclear. In order to determine how FAP-1 affects the signaling mediated by Fas, we set out to identify substrates of FAP-1. Toward this end, we prepared synthetic proteins with either the catalytic domain of FAP-1 (C-terminal 399 amino acids) or its inactive form (Cys2408-->Ser) fused to glutathione-S-transferase (GST). Using an in vitro dephosphorylation reaction, we found that FAP-1 dephosphorylates IkappaBalpha. Furthermore, a substrate trapping mutant was found to bind tyrosine-phosphorylated IkappaBalpha. Taken together, our data confirm that IkappaBalpha is a substrate of FAP-1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106428     DOI: 10.1046/j.1432-1327.2000.01818.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1.

Authors:  Robert Schickel; Sun-Mi Park; Andrea E Murmann; Marcus E Peter
Journal:  Mol Cell       Date:  2010-06-25       Impact factor: 17.970

2.  Interaction of the protein tyrosine phosphatase PTPL1 with the PtdIns(3,4)P2-binding adaptor protein TAPP1.

Authors:  Wendy A Kimber; Maria Deak; Alan R Prescott; Dario R Alessi
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

3.  PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration.

Authors:  Yun-Ju Lai; Weei-Chin Lin; Fang-Tsyr Lin
Journal:  J Biol Chem       Date:  2007-06-25       Impact factor: 5.157

Review 4.  Protein tyrosine phosphatases as potential therapeutic targets.

Authors:  Rong-Jun He; Zhi-Hong Yu; Ruo-Yu Zhang; Zhong-Yin Zhang
Journal:  Acta Pharmacol Sin       Date:  2014-09-15       Impact factor: 6.150

Review 5.  PTPL1: a large phosphatase with a split personality.

Authors:  Ogan D Abaan; Jeffrey A Toretsky
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

6.  Proteins interacting with cloning scars: a source of false positive protein-protein interactions.

Authors:  Charles A S Banks; Gina Boanca; Zachary T Lee; Laurence Florens; Michael P Washburn
Journal:  Sci Rep       Date:  2015-02-23       Impact factor: 4.379

7.  Sildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95.

Authors:  Anindita Das; David Durrant; Clint Mitchell; Paul Dent; Surinder K Batra; Rakesh C Kukreja
Journal:  Oncotarget       Date:  2016-01-26

8.  PTPL1 and PKCδ contribute to proapoptotic signalling in prostate cancer cells.

Authors:  C Castilla; D Chinchón; R Medina; F J Torrubia; M A Japón; C Sáez
Journal:  Cell Death Dis       Date:  2013-04-04       Impact factor: 8.469

9.  Gene expression changes in long-term culture of T-cell clones: genomic effects of chronic antigenic stress in aging and immunosenescence.

Authors:  Dawn J Mazzatti; Andrew White; Rosalyn J Forsey; Jonathan R Powell; Graham Pawelec
Journal:  Aging Cell       Date:  2007-02-05       Impact factor: 9.304

Review 10.  ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation.

Authors:  Melanie Ehrlich; Cecilia Sanchez; Chunbo Shao; Rie Nishiyama; John Kehrl; Rork Kuick; Takeo Kubota; Samir M Hanash
Journal:  Autoimmunity       Date:  2008-05       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.